Novartis CEO Narasimhan Is Encouraged On US Drug Pricing Ahead Of Trump's Announcement

 
• By Jessica Merrill
  
Novartis head of global development Vas Narasimhan
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access